Early Rituximab as an Add-On Therapy in Children With the Initial Episode of Nephrotic Syndrome

Early Rituximab as an Add-On Therapy in Children With the Initial Episode of Nephrotic Syndrome

Introduction: The approximately 70% 12-month relapse in children experiencing the initial episode of steroid-sensitive nephrotic syndrome (SSNS) is a significant concern, with over 50% developing frequent relapses or steroid-dependent nephrotic syndrome (FRNS/SDNS). There is a lack of strategies to...

Full description

Saved in:
Bibliographic Details
Main Authors: Jialu Liu, Fang Deng, Xiaowen Wang, Cuihua Liu, Shuzhen Sun, Ruifeng Zhang, Aihua Zhang, Xiaoyun Jiang, Weili Yan, Yalan Dou, Yi Zhang, Li Xie, Biyun Qian, Qian Shen, Hong Xu
Format: Article
Language:English
Published: Elsevier 2024-05-01
Series:Kidney International Reports
Subjects:
children
pediatric nephrology
rituximab
nephrotic syndrome
clinical trial
proteinuria
Online Access:http://www.sciencedirect.com/science/article/pii/S2468024924014840
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items